Two new Ebola vaccines to join DR Congo clinical trial
UNITED NATIONS · NEW YORK — Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
- REPORT
- RT-8399F5
- SOURCE
- United Nations (UN News)
- TYPE
- Un News
- PUBLISHED
- 05 November 2026 · 12:00 UTC
- FIRST SEEN
- 05 November 2026 · 12:30 UTC
- ORIGINAL
- https://news.un.org/feed/view/en/story/2026/11/1168742
- SHA-256
- 4a8d5a2e55d41ccba0ef735bb4c0a19c0e1547b79de6ffc464ebd61caf672cb2
The fingerprint is the SHA-256 of the original link, the headline and the publication time joined by “|”. Anyone can recompute it to confirm this report was not changed here.
This is an official release published by the United Nations (UN News), shown here as published. Announcements of charges describe allegations; everyone is presumed innocent unless and until proven guilty in court. Corrections: legal@richtvx.app.
More from UNITED NATIONS
Afghanistan restrictions prevent pregnant women from seeking medical helpRT-E32181 · UN NEWS
WFP plans to assist 91 million in 2027 as hunger crisis deepensRT-DE0C6D · UN NEWS
Bridgetown AI summit to tackle safety as risks outpace capacity to respondRT-0B2DF1 · UN NEWS
